
|Articles|June 1, 2003
More patients can try presbyopia reversal
The FDA will allow an increase in the number of clinical trial patients eligible to be treated for presbyopia with SurgiLight's OptiVision system.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
4
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
5

















































.png)


